Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
11/16/1993 | CA1324383C Process for the manufacture of novel substituted aminomethanediphosphonic acids |
11/16/1993 | CA1324381C Aryl-substituted naphthyridine and pyridopyrazine derivatives |
11/11/1993 | WO1993022437A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology |
11/11/1993 | WO1993022436A1 Lectin domain variants of selectin |
11/11/1993 | WO1993022312A1 Deazaaminopterins for treatment of inflammation |
11/11/1993 | WO1993022279A1 Diamine derivatives having selective affinity for sigma receptors |
11/11/1993 | WO1993021956A1 Antibodies to p-selectin and their uses |
11/11/1993 | WO1993021940A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
11/11/1993 | WO1993021936A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
11/11/1993 | WO1993021922A1 Antirheumatic |
11/11/1993 | WO1993021912A1 Use of an emulsion containing omega-3 fatty acids to produce a medicament to be parenterally administered for treating inflammatory diseases |
11/11/1993 | WO1993021889A1 Method for hyperthermic potentiation of tissue |
11/11/1993 | CA2133580A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
11/11/1993 | CA2133442A1 Deazaaminopterins for treatment of inflammation |
11/11/1993 | CA2112665A1 Pharmaceutical compositions for curing rheumatism |
11/11/1993 | CA2112490A1 Diamine derivatives having selective affinity for sigma receptors |
11/10/1993 | EP0569337A1 Heteroatoms-containing tricyclic compounds |
11/10/1993 | EP0569042A1 Medical uses of IL-1 beta |
11/10/1993 | EP0568645A1 Mixed specificity fusion proteins |
11/10/1993 | EP0568631A1 Monoclonal antibodies to elam-1 and their uses |
11/10/1993 | EP0568623A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
11/09/1993 | US5260422 MHC conjugates useful in ameliorating autoimmunity |
11/09/1993 | US5260335 Pharmaceutical preparations for the treatment of inflammatory diseases |
11/09/1993 | US5260329 Angiogenesis inhibitors |
11/09/1993 | US5260313 Diagnosis and treatment of various neuralgias |
11/09/1993 | US5260210 Blood-brain barrier model |
11/09/1993 | CA1324143C Quinoline dioic acids and amides |
11/09/1993 | CA1324134C Process for preparing (rs)-2-(2,3-dihydro-5-hydroxy-4,6, 7-trimethylbenzofuranyl) acetic acids and 2-(2,3-dihydro-5-acyloxy-4,6,7-trimethylbenzofuranyl) acetic acids and esters thereof, useful as mucoregulator and antihyschaemic drugs |
11/09/1993 | CA1324130C Oxaza heterocycles and pharmaceutical compositions containing same |
11/03/1993 | EP0568289A2 Benzothiophenes and thienothiophenes and related compounds useful, for example, as urokinase inhibitors |
11/03/1993 | EP0568026A2 Piroxicam tablets and production process thereof |
11/03/1993 | EP0567966A1 Cyclic imino derivatives, medicaments containing these compounds and processes for the production thereof |
11/03/1993 | EP0567816A1 Use of inhibitors of plasminogen activators for treating of inflammations and wounds |
11/03/1993 | EP0567566A1 Methods for treating tumor necrosis factor mediated diseases |
11/03/1993 | CN1077958A Triazolopyridazine compounds, their production and use |
11/03/1993 | CN1022626C Process for preparation of furan derivatives |
11/02/1993 | US5258513 Substituted cyclopropylamino-1,3,5-triazines |
11/02/1993 | US5258377 2-spirocyclopropyl 4-acylcephems |
11/02/1993 | US5258371 Method to reduce connective tissue destruction |
11/02/1993 | CA2094332A1 Urokinase inhibitors |
11/02/1993 | CA1323837C Solid, rapidly disintegrating dosage form |
10/31/1993 | CA2095207A1 Use of inhibitors of plasminogen activators for the treatment of inflammations and wounds |
10/29/1993 | CA2095086A1 Piroxicam tablets and production process thereof |
10/29/1993 | CA2095009A1 Cyclic imino derivatives |
10/28/1993 | WO1993021227A1 Tachykinin antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds |
10/28/1993 | WO1993021215A1 Peptides having tachykinin antagonist activity |
10/28/1993 | WO1993021214A1 Alpha-aminoboronic acid peptides and their use as elastase inhibitors |
10/28/1993 | WO1993021213A1 Alpha-aminoboronic acid peptides and their use as elastase inhibitors |
10/28/1993 | WO1993021212A1 Lactam dipeptides having hle inhibiting activity |
10/28/1993 | WO1993021210A1 Pyrimidinyl acetamides as elastase inhibitors |
10/28/1993 | WO1993021209A1 Lactam peptides having hle inhibiting activity |
10/28/1993 | WO1993021198A1 Novel sialylsteroid |
10/28/1993 | WO1993021159A1 Quinoline derivatives as leukotriene antagonists |
10/28/1993 | WO1993021155A1 Perhydroisoindole derivatives as p substance antagonists |
10/28/1993 | WO1993021149A1 Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase |
10/28/1993 | WO1993020850A1 Pharmaceutical composition |
10/28/1993 | WO1993019024A3 Mercapto-acetamide derivatives |
10/28/1993 | CA2133840A1 Perhydroisoindole derivatives used as p substance antagonists |
10/28/1993 | CA2133659A1 Pyrimidinyl acetamides as elastase inhibitors |
10/28/1993 | CA2133658A1 Heterocyclic derivatives |
10/28/1993 | CA2133657A1 Substituted derivatives |
10/28/1993 | CA2132543A1 Lactam dipeptides having hle inhibiting activity |
10/28/1993 | CA2118503A1 Peptides having tachykinin antagonist activity |
10/28/1993 | CA2118253A1 Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds |
10/28/1993 | CA2118250A1 Lactam peptides having hle inhibiting activity |
10/28/1993 | CA2117762A1 Pharmaceutical composition |
10/27/1993 | EP0566709A1 Composition comprising a tramadol compound and acetaminophen, and its use |
10/27/1993 | EP0566647A1 Improved humanized immunoglobulins |
10/27/1993 | EP0566593A1 N-hydroxyurea derivatives as antiallergy and antiinflammatory agents |
10/27/1993 | EP0566589A1 N-alkyl quinuclidinium salts as substance p antagonists |
10/26/1993 | US5256789 Antiinflammatory hydroxamic acids and N-hydroxyureas |
10/26/1993 | US5256671 A prodrug as tachykinin antagonists for treating headaches, pain or inflammation |
10/26/1993 | US5256642 Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof |
10/26/1993 | US5256411 Immune cell proliferation inhibitors |
10/26/1993 | CA1323577C Emulsified external treatment composition containing diclofenac sodium |
10/24/1993 | CA2094465A1 Cycloalkane derivatives |
10/20/1993 | EP0566446A1 Derivatives of indane-1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy |
10/20/1993 | EP0566445A1 Derivatives of indane 1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy |
10/20/1993 | EP0566393A1 Stabilized solid pharmaceutical preparation and method of producing the same |
10/20/1993 | EP0565582A1 Novel csaids |
10/20/1993 | EP0413692B1 Use of hexatriene derivatives for the manufacture of preparations for treating acne, psoriasis and light-induced damage to the skin |
10/19/1993 | US5254728 Complexes containing S(+)-phenyl alkanoic acids and α-hydroxyalkanoic |
10/19/1993 | US5254583 Salts of 2-(2,6-dichloroanilino)-phenylacetic acid, a process for their preparation and their use for pharmaceutical preparations to be applied locally |
10/19/1993 | US5254558 Treating respiratory system and cardiovascular disorders |
10/19/1993 | US5254554 Anxiolytic agents |
10/19/1993 | US5254546 Fused aryl substituted imidazole angiotensin II receptor inhibitors |
10/19/1993 | CA1323306C Pharmacological agent-lipid solution preparation |
10/14/1993 | WO1993020102A1 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis |
10/14/1993 | WO1993020059A1 Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans |
10/14/1993 | WO1993020058A1 Novel cardioprotective agents |
10/14/1993 | WO1993020047A1 Hydroxamic acid based collagenase and cytokine inhibitors |
10/14/1993 | WO1993020046A1 Indan-1,3-dione and indan-1,2,3-trione derivatives, processes for preparation of same and their use as therapeutic agents |
10/14/1993 | WO1993020045A1 Indan-1,3-dione and indan-1,2,3-trione derivatives, processes for the preparation of same and their application as therapeutic agents |
10/14/1993 | WO1993019782A1 Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
10/14/1993 | WO1993019769A1 Wound healing and treatment of fibrotic disorders |
10/14/1993 | WO1993019755A1 Medicament for the treatment of airways inflammation and airways hyperresponsiveness |
10/14/1993 | WO1993019751A1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor |
10/14/1993 | WO1993019750A1 Compounds useful for treating allergic or inflammatory diseases |
10/14/1993 | WO1993019749A1 Compounds useful for treating allergic and inflammatory diseases |
10/14/1993 | WO1993019748A1 Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor |